AVANIR Pharmaceuticals, Inc. · Aliso Viejo, CA United States (NASDAQ: AVNR)
| 101 Enterprise, Ste. 300 | Phone: 949-389-6700 |
| Aliso Viejo, CA | Fax: 949-643-6800 |
| 92656 | |
| United States | 
Map This Company |
AVANIR Pharmaceuticals, Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
AVANIR Pharmaceuticals doesn't have anything against tears, it just wants them to be triggered by emotions instead of central nervous system disorders. Its drug NUEDEXTA has been approved as a treatment for pseudobulbar affect -- the involuntary crying or laughing experienced by some people with neurological disorders, such as multiple sclerosis, or following brain injury or stroke. NUEDEXTA is also in late-stage trials for diabetic neuropathic pain. AVANIR had an earlier success with its development of OTC cold sore cream Abreva, which
AVANIR Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: AVNR Headquarters |
|---|---|
| Fiscal Year-End | September |
| 2010 Employees | 128 |
Executives
20 executives listed for AVANIR Pharmaceuticals, Inc.'s Aliso Viejo, CA location.
| President, CEO, and Director | Keith Katkin | |
|---|---|---|
| VP Finance | Christine Ocampo | |
| SVP Clinical Research and Clinical Research and Chief Medical Officer | Randall Kaye |